TITLE

Which patients receiving warfarin can be treated safely with a drug-eluting stent?

AUTHOR(S)
Ryding, A. D. S.; Banning, A. P.
PUB. DATE
March 2008
SOURCE
Heart;Mar2008, Vol. 94 Issue 3, p275
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on the effectiveness of warfarin with a combination of a drug-eluting stent (DES) technology. It discusses the emergence and effectiveness of the DES technology replacing the in-stent restenosis. However, the problem in stent thrombosis has been cited due to the manipulation of the healing processes and it takes time in stent implantation.
ACCESSION #
31301580

 

Related Articles

  • Economical anticoagulation depends on age, sex.  // PharmacoEconomics & Outcomes News;8/13/2005, Issue 484, p10 

    Discusses a study on oral anticoagulation strategies after a first idiopathic venous thromboembolic event. Factors associated with the cost effectiveness of anticoagulation strategies in patients who have experienced a first idiopathic venous thromboembolic event; Use of a Markov model in the...

  • Does warfarin prevent deep venous thrombosis in high-risk patients?  // Journal of Family Practice;Mar2004, Vol. 53 Issue 3, p230 

    This article argues that warfarin is effective in preventing deep venous thrombosis (DVT) among patients with a history of DVT. Conventional dosing and longer durations are the most effective, but the ideal length of therapy is unknown. Warfarin is useful in preventing DVT in patients with...

  • Successful Percutaneous Balloon Mitral Valvuloplasty in a Patient with Left Atrial Thrombus. Nseir, Georges; Kwan, Tak; Mandawat, Mahandra; Feit, Alan; Clark, Luther T. // Angiology;Mar1999, Vol. 50 Issue 3, p255 

    Percutaneous balloon mitral valvuloplasty (PBMV) described by Inoue et al, is a safe FDA (Food and Drug Administration) approved procedure in patients with severe mitral stenosis. One of the contraindications of the procedure is presence of a left atrial thrombus; however, it has been reported...

  • 2009 - Warfarin thromboprophylaxis in cancer did not reduce risk for catheter-related thrombosis. Siragusa, Sergio // ACP Journal Club;7/21/2009, Vol. 151 Issue 1, p3 

    The article focuses on a study investing reduction of catheter-related thrombosis by warfarin compared with no warfarin, or by dose-adjusted warfarin compared with fixed-dose warfarin in patients with cancer receiving chemotherapy through central venous catheters (CVCs). The results concluded...

  • Warfarin. Gabat, Alan G. // Review of Optometry;Oct2007 Supplement, Vol. 144, p14 

    The author reflects on the medicinal application of warfarin among thrombosis patients in the U.S. He argued that warfarin was organically developed as pesticide, particularly as a rat poison. Furthermore, he inferred that warfarin is common anticoagulant and is mostly used to treat a variety of...

  • Compression Stockings and Post-Thrombotic Syndrome. Shaughnessy, Allen F. // American Family Physician;1/1/2005, Vol. 71 Issue 1, p144 

    Deals with whether off-the-shelf compression stockings can prevent post-thrombotic syndrome in patients with a proximal deep venous thrombosis. Patients who were diagnosed with mild post-thrombotic syndrome in the study; List of post-thrombotic symptoms.

  • Experimental antithrombotic effect of potatoes harvested in the autumn. Yamamoto, Junichiro; Masuda, Megumi; Hyodo, Kanae; Iwasaki, Masahiro // Health (1949-4998);Feb2012, Vol. 4 Issue 2, p108 

    Prevention of arterial thrombotic diseases has a high priority in developed countries. While an inappropriate diet is known to enhance the risk for acute thrombotic events, a regular diet with proven antithrombotic effects might be beneficial in the prevention of such diseases. The present study...

  • Hereditary and Acquired Thrombophilic Disorders. Bick, Rodger L. // Clinical & Applied Thrombosis/Hemostasis;Apr2006, Vol. 12 Issue 2, p125 

    Presents research which assessed hereditary and acquired thrombophilic disorders. Percentage of deaths in the U.S. caused by thrombosis; Influence of hemorrhage on the development of dysfibrinogenemia; Association of hyperhomocystinemia with arterial and venous thrombosis; Impact of heparin...

  • The ABCs of DVT. Sprizza, Lori; Witko, Audrey // MEDSURG Nursing;Dec2003, Vol. 12 Issue 6, p403 

    Provides information on deep vein thrombosis (DVT). Factors that initiate the clotting process in the blood and increase the likelihood of clot formation; Clinical symptoms and signs of DVT; Nursing implications.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics